Literature DB >> 2351623

Penicillin-binding proteins and ampicillin resistance in Haemophilus influenzae.

P M Mendelman1, D O Chaffin, G Kalaitzoglou.   

Abstract

Ampicillin-resistant, non-beta-lactamase-producing isolates of Haemophilus influenzae contain a variety of penicillin-binding protein (PBP) patterns that differ from the single pattern of eight PBPs characteristic of susceptible strains. During genetic transformation of resistance, only some of the anomalies in PBP pattern were transformed, specifically those relating to the penicillin-binding capacities of PBPs 4 (Mr of 62,000) and 5 (Mr of 59,000) and, in some transformations, PBP 3 (Mr of 71,000). Comparison of the binding of penicillin by PBPs 4 and 5 of three resistant transformants (derived with DNA from different donors) revealed a decrease in the rate of PBP acylation and no appreciable change in the rate of deacylation as compared to the susceptible recipient. Thus, rapid turnover of these PBPs does not play a role. Retransformation studies confirm that altered PBPs 3, 4, and 5 are associated with resistance and suggest that these PBPs are major targets for the beta-lactam antibiotics in H. influenzae.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2351623     DOI: 10.1093/jac/25.4.525

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  13 in total

1.  Association of amino acid substitutions in penicillin-binding protein 3 with beta-lactam resistance in beta-lactamase-negative ampicillin-resistant Haemophilus influenzae.

Authors:  K Ubukata; Y Shibasaki; K Yamamoto; N Chiba; K Hasegawa; Y Takeuchi; K Sunakawa; M Inoue; M Konno
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

2.  Diversity of ampicillin resistance genes and antimicrobial susceptibility patterns in Haemophilus influenzae strains isolated in Korea.

Authors:  In-Suk Kim; Chang-Seok Ki; Sunjoo Kim; Won Sup Oh; Kyong Ran Peck; Jae-Hoon Song; Kyungwon Lee; Nam Yong Lee
Journal:  Antimicrob Agents Chemother       Date:  2006-11-20       Impact factor: 5.191

Review 3.  Penicillin-binding proteins and bacterial resistance to beta-lactams.

Authors:  N H Georgopapadakou
Journal:  Antimicrob Agents Chemother       Date:  1993-10       Impact factor: 5.191

4.  Interpretive criteria for susceptibilities of Haemophilus influenzae to ampicillin, amoxicillin, and amoxicillin-clavulanic acid.

Authors:  P C Fuchs; A L Barry
Journal:  J Clin Microbiol       Date:  1994-11       Impact factor: 5.948

Review 5.  Clinical relevance of antibiotic-induced endotoxin release.

Authors:  J M Prins; S J van Deventer; E J Kuijper; P Speelman
Journal:  Antimicrob Agents Chemother       Date:  1994-06       Impact factor: 5.191

Review 6.  The development of beta-lactam antibiotics in response to the evolution of beta-lactamases.

Authors:  S Y Essack
Journal:  Pharm Res       Date:  2001-10       Impact factor: 4.200

7.  Effect of the inoculum size on carbapenem susceptibilities of beta-lactamase-negative, ampicillin-resistant Haemophilus influenzae.

Authors:  Hiroo Miyazaki; Toshinobu Horii; Osanori Nagura; Takafumi Suda; Kingo Chida; Hirotoshi Nakamura
Journal:  Curr Microbiol       Date:  2008-09-25       Impact factor: 2.188

Review 8.  Three decades of beta-lactamase inhibitors.

Authors:  Sarah M Drawz; Robert A Bonomo
Journal:  Clin Microbiol Rev       Date:  2010-01       Impact factor: 26.132

9.  Genetic characteristics and clonal dissemination of beta-lactamase-negative ampicillin-resistant Haemophilus influenzae strains isolated from the upper respiratory tract of patients in Japan.

Authors:  Muneki Hotomi; Keiji Fujihara; Dewan S Billal; Kenji Suzuki; Tadao Nishimura; Shunkichi Baba; Noboru Yamanaka
Journal:  Antimicrob Agents Chemother       Date:  2007-08-13       Impact factor: 5.191

10.  Molecular epidemiology of ampicillin-resistant non-beta-lactamase-producing Haemophilus influenzae.

Authors:  L Gazagne; C Delmas; E Bingen; H Dabernat
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.